Cencora (NYSE:COR) Q4 2024 Earnings Call Transcript
Operator: Hello, everyone, and welcome to today's Cencora Q4 Full Year 2024 Earnings Call. My name is Drew, and I'll be the operator today. During today's call, there will be a Q&A session.
Cencora Inc. (COR)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Two Sigma Advisors John Overdeck And David Siegel | 1,638,400 | $368,771,072 | +22% | 0.86% |
| 2. | AQR Capital Management Cliff Asness | 1,461,159 | $328,044,860 | +35% | 0.45% |
| 3. | Arrowstreet Capital Peter Rathjens, Bruce Clarke And John Campbell | 970,186 | $218,369,465 | -9% | 0.18% |
| 4. | Holocene Advisors Brandon Haley | 697,785 | $157,057,448 | +17% | 0.63% |
| 5. | Marshall Wace LLP Paul Marshall And Ian Wace | 495,854 | $111,606,819 | +7162% | 0.13% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $218.58 | 500 | Director | 21,876 | 2024-05-24 | Filing | |
| $74.33 | 1,350 | Director | 6,717 | 2020-03-23 | Filing | |
| $82.62 | 1,225 | Director | 5,367 | 2020-03-13 | Filing | |
| $80.53 | 11 | Officer | 7,437 | 2019-03-05 | Filing | |
| $88.44 | 10 | Officer | 7,437 | 2018-12-04 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $235.80 | 21,509 | Officer, Director | 285,088 | 2024-10-22 | Filing | |
| $241.01 | 21,509 | Officer, Director | 285,088 | 2024-09-17 | Filing | |
| $239.13 | 10,754 | Officer, Director | 285,088 | 2024-08-20 | Filing | |
| $242.69 | 1,473 | Officer | 10,948 | 2024-08-06 | Filing | |
| $240.56 | 4,438,171 | 19,980,000 | 2024-08-01 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 20,510,739 | $4,212,495,576 | 0.09% | |
| 2. | 19,677,848 | $4,041,436,442 | 0.1% | |
| 3. | 7,896,643 | $1,621,812,539 | 0.07% | |
| 4. | 5,457,450 | $1,120,851,076 | 0.11% | |
| 5. | 4,624,044 | $949,686,355 | 0.07% |
News See All
Goldman Sachs' List Of Stocks That Hedge & Mutual Funds Love & Hate: 28 Stocks On The Mutual and Hedge Funds Radar
The surge in interest surrounding artificial intelligence has meant that the stock market in 2024 has continued to surprise.
Cencora (COR) Fell Due to Temporary Supply Constraints on Anti-Obesity Drugs
TimesSquare Capital Management, an equity investment management company, released its “U.S. Focus Growth Strategy” second-quarter 2024 investor letter.
Cencora (NYSE:COR) Q3 2024 Earnings Call Transcript
Operator: Good morning and good afternoon, ladies and gentlemen. Welcome to the Cencora Q3 Earnings Call. My name is Jaquita. I will be your moderator for today's call.
Cencora (COR) Rose 19% in Q1
TimesSquare Capital Management, an equity investment management company, released its “U.S. Focus Growth Strategy” first-quarter investor letter. A copy of the letter can be downloaded here.
Cencora (NYSE:COR) Q2 2024 Earnings Call Transcript
Cencora beats earnings expectations. Reported EPS is $3.8, expectations were $3.69.
Cencora (COR) Reported a Strong Q4 and Rose 14%
TimesSquare Capital Management, an equity investment management company, released its “U.S. Mid Cap Growth Strategy” fourth-quarter investor letter. A copy of the same can be downloaded here.
13 Best Pharma Dividend Stocks To Buy in 2024
In this article, we discuss 13 best pharma dividend stocks to buy in 2024.
30 Largest Companies in the World by Revenue
In this article, we will be taking a look at the 30 largest companies in the world by revenue.
Cencora (NYSE:COR) Q1 2024 Earnings Call Transcript
Cencora beats earnings expectations. Reported EPS is $3.28, expectations were $2.85.